Status:
COMPLETED
Same Day Discharge Following Pelvic Reconstructive Surgery
Lead Sponsor:
TriHealth Inc.
Conditions:
Same Day Discharge
Pelvic Organ Prolapse
Eligibility:
FEMALE
18+ years
Brief Summary
This is a prospective cross-sectional study in which patients undergoing major pelvic reconstructive surgery with total vaginal hysterectomy will be recruited and enrolled. At approximately 2 weeks an...
Eligibility Criteria
Inclusion
- Total vaginal hysterectomy with or without bilateral salpingectomy/oophorectomy
- Apical repair with uterosacral ligament suspension or sacrospinous ligament fixation
- They may also have any of the following concurrent procedures: Anterior repair, Posterior repair, Enterocele repair, Suburethral sling for incontinence
- Surgery by one of the fellowship trained urogynecologists at TriHealth
- English speaking
Exclusion
- Enrollment in the "Diazepam Research Study" (Protocol ID:19-130)
- Concomitant procedure with another surgeon
- Chronic pain conditions that require daily use of narcotic pain medications (including but not limited to: chronic back or pelvic pain, interstitial cystitis, fibromyalgia)
- Concomitant anal sphincteroplasty, mesh removal or use of mesh for prolapse (excluding sling procedures)
Key Trial Info
Start Date :
June 14 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 6 2022
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04804826
Start Date
June 14 2021
End Date
April 6 2022
Last Update
February 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Urogynecology Associates
Cincinnati, Ohio, United States, 45220